The global fetal bovine serum market size was US$ 850 million in 2021. The global fetal bovine serum market is forecast to reach US$ 1,440 billion by 2030 by growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2022-2030.

Fetal bovine serum is derived from a bovine fetus. The fetus produced in the meat processing industries is an efficient supplement that could help bring advancements in biotechnology and diagnostic sectors.

Factors Influencing the Market

The increasing prevalence of diseases is the primary factor driving the growth of the fetal bovine serum market.
Growing research and development and increasing demand for novel drugs will accelerate the growth of the fetal bovine serum market during the forecast period.
Rising investment in the medical sector will propel the fetal bovine serum market forward. Furthermore, growing government initiatives and increasing healthcare spending will contribute to the growth of the global fetal bovine serum market during the forecast period. Various governments are providing financial aid and adopting measures to promote the use of fetal bovine serum. As a result, it will have a positive impact on fetal bovine serum sales.
However, the high cost of fetal bovine serum may restrict its adoption.
COVID-19 Impact Analysis

The global fetal bovine serum market was positively influenced by the COVID-19 pandemic. Due to this health emergency, the demand for novel drugs surged steeply. As a result, the demand for fetal bovine serum also increased. Furthermore, the COVID-19 infection spread rapidly. Governments of various countries shifted all their focus on the healthcare segment. It offered ample growth opportunities for the global fetal bovine serum market.

Regional Analysis

North America is forecast to dominate the global fetal bovine serum market in terms of revenue. The growth of the regional fetal bovine serum market is attributed to the high healthcare expenditure and increasing prevalence of diseases. In addition, increasing awareness about fetal bovine serum and the growing demand for novel drugs will benefit the market in the coming years. Asia-Pacific and Europe are forecast to hold the second and third largest share. It is due to the growing medical infrastructure in these regions. Furthermore, growing government initiatives and increasing the prevalence of diseases will surge the growth of these markets.

Competitors in the Market

Access Biologics
Animal Technologies
Atlanta Biologics Inc.
Bio-Techne
Bovogen Biologics Ltd
Corning Incorporated
GE Healthcare
HiMedia Laboratories
Merck KGaA
Nucleus Biologics
PAN-Biotech
Rocky Mountain Biologics
TCS Biosciences Ltd
Thermo Fisher Scientific Inc.
Tissue Culture Biologics
Other Prominent Players
Market Segmentation

The global fetal bovine serum segmentation market study focuses on Type, Application, End-User, and Region.

The fetal bovine serum market has been segmented based on type

Charcoal Stripped
Chromatographic
Exosome Depleted
Stem Cell
Others
The fetal bovine serum market has been segmented based on application

Drug Discovery
Cell Culture Media
In Vitro Fertilization
Diagnostics
Others
The fetal bovine serum market has been segmented based on the end-user

Pharmaceutical
Research & Academic Institutes
Others
The fetal bovine serum market has been segmented based on region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America